Manufacturing and Production

Showing 15 posts of 5869 posts found.

Pfizer issues guide for medicines disposal

September 18, 2012 Manufacturing and Production EPA, PRDA, Pfizer

Pfizer has published a guide for the safe disposal of medicines targeted at healthcare professionals and facilities in the US. …
Mark Mallon image

Asia-Pacific – pharma’s new centre of gravity?

September 18, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia-Pacific, AstraZeneca

A high-growth region for the pharmaceutical industry, Asia-Pacific incorporates a vast geography with a $20 trillion economy, and is home …

SHL to Exhibit at 2012 PDA Event in Las Vegas – Inspiring Integration

September 18, 2012 Manufacturing and Production auto injector, autoinjector, inspiring integration, pen injector, shl group

With the biopharmaceutical industry’s drug delivery landscape quickly adapting to the introduction of several biologics drugs in recent years, a …
UCB image

UCB opens Belgian pilot plant

September 17, 2012 Manufacturing and Production Amgen, Belgium, R&D, UCB

UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …

Pharma manufacturing news in brief

September 17, 2012 Manufacturing and Production Ampio, DPT Labs, Ethypharm, ICH, PC Pharma, Ranbaxy

Ranbaxy and PC Pharma unveil new facility investments, Ethypharm will manufacture Ampio drug, DPT Labs is warned by the FDA …

Pfizer and Hisun sign China generics deal

September 13, 2012 Manufacturing and Production, Sales and Marketing China, Pfizer, branded generics, emerging markets, generics

Pfizer has unveiled a new joint venture with with China’s Zhejiang Hisun Pharmaceuticals. It is one of the first joint …
The RNAi therapeutic mechnism

New frontiers in drug discovery

September 11, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing RNA, drug discovery, therapeutic

Despite the success of small molecule and biologic drugs such as monoclonal antibodies, there remain many areas of unmet medical …
dr_brett_haumann

Circassia appoints GSK’s Dr Brett Haumann

September 11, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brett Haumann, Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Brett Haumann as chief medical officer. Haumann joins allergy-focussed Circassia …
Patheon image

Patheon offloads clinical packaging ops

September 11, 2012 Manufacturing and Production Bellwyck, Ontario, Patheon

Patheon has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions as it continues …
Takeda HQ image

Takeda opens Russian manufacturing facility

September 11, 2012 Manufacturing and Production Actovegin, Nycomed, Russia, Takeda

Takeda Pharmaceutical has officially opened its new manufacturing facility in Yaroslavl, Russia, and expects it to be operating at full …
MedImmune

MedImmune signs China deal

September 11, 2012 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis

MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …
screen_shot_2012-09-10_at_10

Ex-Pfizer head joins Red Door as International director

September 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Thomas, Pfizer, Red Door

Andrew Thomas the strategic communications lead for Pfizer’s primary care medicines across Europe and Canada joins Red Door Communications in …

New product launches – maximise your chance of success

September 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch

You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …

Brazil delays excipient GMP deadline

September 6, 2012 Manufacturing and Production ANVISA, Brazil, GMP

Brazil’s national medicines regulatory agency ANVISA has delayed proposed new rules on good manufacturing practice (GMP) for pharmaceutical excipients after …

Hospira buys Indian antibiotic plant

September 6, 2012 Manufacturing and Production Hospira, India

US injectable drugs specialist Hospira has announced plans to expand in India via the purchase of a manufacturing facility and …
The Gateway to Local Adoption Series

Latest content